The latest report by IMARC Group, titled “Sexually Transmitted Disease (STD) Diagnostics Market Report by Type (Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing, Chancroid Testing, and Others), Device Type (Laboratory Devices, Point of Care (PoC) Devices), End User (Laboratory Testing, Point of Care (PoC) Testing), and Region 2024-2032“, The global sexually transmitted disease (STD) diagnostics market size reached US$ 104.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 159.5 Billion by 2032, exhibiting a growth rate (CAGR) of 4.71% during 2024-2032.
STD diagnostics involve the use of a variety of scientific tools and methods to detect and confirm the presence of sexually transmitted diseases in individuals. These methods include PCR tests, NAATs, ELISAs, PoC devices, and self-testing kits. They are essential for identifying and screening a wide range of STDs, such as genital herpes, chlamydia, gonorrhea, syphilis, and more, by analyzing blood, urine, genital swabs, and fluid samples for pathogens and markers associated with these diseases. Early and accurate diagnosis through these techniques, including for gonorrhea, herpes, hepatitis B and C, HIV, and HPV, allows for prompt intervention, prevention of complications, and improved patient outcomes. Physicians worldwide are increasingly recognizing the importance of STD diagnostics in understanding and addressing these diseases.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/sexually-transmitted-disease-diagnostics-market/requestsample
Sexually Transmitted Disease (STD) Diagnostics Market Trends and Drivers:
The global market for STD diagnostics is growing due to several factors, including the increasing number of STD cases resulting from unprotected sex and drug abuse. Additionally, the use of diagnostics to assess the severity of infections, prevent transmission, and determine appropriate treatment options is also driving market growth. The rising awareness among the general population about the importance of early disease detection to prevent complications such as cancer, congenital disabilities, and infertility has also contributed to the market growth. The development of multiplex assays, which enable the simultaneous detection of multiple STD pathogens in a single test, has accelerated product adoption. Self-testing kits have also empowered individuals to conveniently test for STDs in the privacy of their homes, improving accessibility, patient comfort, and confidentiality. Governments' initiatives to educate the masses about STDs, promote timely disease diagnosis, and provide better access to high-quality treatment and testing facilities are also contributing to the market growth. Finally, rising healthcare expenditure, surging investments in advanced diagnostic tools, and the increasing emphasis on sexual health among individuals are expected to drive the market further.
Report Segmentation:
The report has segmented the market into the following categories:
Type Insights:
- Chlamydia Testing
- Syphilis Testing
- Gonorrhea Testing
- Herpes Simplex Virus Testing
- Human Papilloma Virus Testing
- Human Immunodeficiency Virus Testing
- Chancroid Testing
- Others
Device Type Insights:
- Laboratory Devices
- Thermal Cycler – PCR
- Lateral Flow Readers
- Flow Cytometers
- Absorbance Microplate Reader – Enzyme Linked Immunosorbent Assay (ELISA)
- Others
- Point of Care (PoC) Devices
- Phone Chips (Microfluidics + ICT)
- Portable/Bench Top/Rapid Diagnostic Kits
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Abbott Laboratories
- Becton Dickinson and Company
- BioMérieux SA
- Bio-Rad Laboratories Inc.
- Cepheid (Danaher Corporation)
- F. Hoffmann-La Roche AG
- Hologic Inc., Qiagen N.V.
- Quidel Corporation
- Siemens Healthineers AG (Siemens AG)
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 |United Kingdom: +44-753-713-2163
